Ares Capital Earnings Calls
| Release date | Apr 28, 2026 |
| EPS estimate | $0.480 |
| EPS actual | $0.470 |
| EPS Surprise | -2.08% |
| Revenue estimate | 778.003M |
| Revenue actual | 763M |
| Revenue Surprise | -1.93% |
| Release date | Feb 04, 2026 |
| EPS estimate | $0.500 |
| EPS actual | $0.500 |
| Revenue estimate | 793.023M |
| Revenue actual | 793M |
| Revenue Surprise | -0.0028% |
| Release date | Oct 28, 2025 |
| EPS estimate | $0.503 |
| EPS actual | $0.500 |
| EPS Surprise | -0.596% |
| Revenue estimate | 768.058M |
| Revenue actual | 655M |
| Revenue Surprise | -14.72% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.506 |
| EPS actual | $0.500 |
| EPS Surprise | -1.19% |
| Revenue estimate | 748.826M |
| Revenue actual | 579M |
| Revenue Surprise | -22.68% |
Last 4 Quarters for Ares Capital
Below you can see how ARCC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 29, 2025 |
| Price on release | $22.54 |
| EPS estimate | $0.506 |
| EPS actual | $0.500 |
| EPS surprise | -1.19% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $23.07 |
| Jul 24, 2025 | $23.03 |
| Jul 25, 2025 | $23.11 |
| Jul 28, 2025 | $22.70 |
| Jul 29, 2025 | $22.54 |
| Jul 30, 2025 | $22.63 |
| Jul 31, 2025 | $22.63 |
| Aug 01, 2025 | $22.39 |
| Aug 04, 2025 | $22.40 |
| 4 days before | -2.30% |
| 4 days after | -0.621% |
| On release day | 0.399% |
| Change in period | -2.90% |
| Release date | Oct 28, 2025 |
| Price on release | $20.57 |
| EPS estimate | $0.503 |
| EPS actual | $0.500 |
| EPS surprise | -0.596% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $19.96 |
| Oct 23, 2025 | $19.94 |
| Oct 24, 2025 | $20.08 |
| Oct 27, 2025 | $20.32 |
| Oct 28, 2025 | $20.57 |
| Oct 29, 2025 | $20.61 |
| Oct 30, 2025 | $20.15 |
| Oct 31, 2025 | $20.35 |
| Nov 03, 2025 | $20.41 |
| 4 days before | 3.06% |
| 4 days after | -0.778% |
| On release day | 0.194% |
| Change in period | 2.25% |
| Release date | Feb 04, 2026 |
| Price on release | $19.56 |
| EPS estimate | $0.500 |
| EPS actual | $0.500 |
| Date | Price |
|---|---|
| Jan 29, 2026 | $20.16 |
| Jan 30, 2026 | $19.89 |
| Feb 02, 2026 | $19.52 |
| Feb 03, 2026 | $19.13 |
| Feb 04, 2026 | $19.56 |
| Feb 05, 2026 | $18.79 |
| Feb 06, 2026 | $19.31 |
| Feb 09, 2026 | $19.48 |
| Feb 10, 2026 | $19.96 |
| 4 days before | -2.98% |
| 4 days after | 2.04% |
| On release day | -3.94% |
| Change in period | -0.99% |
| Release date | Apr 28, 2026 |
| Price on release | $18.92 |
| EPS estimate | $0.480 |
| EPS actual | $0.470 |
| EPS surprise | -2.08% |
| Date | Price |
|---|---|
| Apr 22, 2026 | $19.10 |
| Apr 23, 2026 | $18.62 |
| Apr 24, 2026 | $18.67 |
| Apr 27, 2026 | $18.61 |
| Apr 28, 2026 | $18.92 |
| Apr 29, 2026 | $18.67 |
| Apr 30, 2026 | $19.16 |
| May 01, 2026 | $19.25 |
| May 04, 2026 | $19.18 |
| 4 days before | -0.94% |
| 4 days after | 1.37% |
| On release day | -1.32% |
| Change in period | 0.419% |
Ares Capital Earnings Call Transcript Summary of Q1 2026
Ares Capital (ARCC) reported solid first-quarter 2026 results with core EPS of $0.47 (annualized ROE ~9.6%) and GAAP net income per share of $0.13. Portfolio fair value totaled $29.5 billion and NAV was $19.59 per share. Management highlighted healthy portfolio fundamentals: low nonaccruals (2.1% at cost; 1.2% at fair value), ~9% weighted average LTM EBITDA growth for borrowers, broad diversification (607 companies, average position <20 bps) and a conservative balance sheet with approximately $6 billion of available liquidity. Management sees an improving investment backdrop as market volatility and reduced competition have widened spreads (~50–75 bps total improvement noted) and lowered leverage/loans-to-value on new deals, creating opportunities for large, well-capitalized platforms. ARCC originated ~$3.2 billion in Q1 (70% to existing borrowers), recorded $114 million net realized gains, and maintains a stable quarterly dividend of $0.48 (payable June 30). The company engaged a top-tier consulting firm to assess AI risk across its software portfolio and reported the consultant found ~85% of software exposure (by fair value) to be low risk. Management emphasized diversified funding sources, active liability management (issued $750M 5-year notes, expanded a $500M SMBC facility), and that ~70% of Q1 marks were due to mark-to-market spread widening rather than credit deterioration. Backlog was ~$1.8 billion (through April 23) with earlier deals reflecting ~35 bps increase in spreads and ~40 bps increase in fees versus Q1 first-lien loans. Management reiterated discipline on underwriting, vigilance on AI/software exposure, and confidence in ARCC’s ability to deploy capital opportunistically given its liquidity and scale.
Sign In
Buy ARCC